drugset / Trial / NCT02704702

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Rosuvastatin in Healthy Male Subjects

NCT02704702

Phase 1 Completed 36 enrolled Boryung Pharmaceutical Co., Ltd
RandomizedCrossoverOpen-labelOther

Summary

The purpose of this study is to evaluate the pharmacokinetics and safety of Fimasartan and rosuvastatin when coadministered or administered alone as a single dose or as multiple doses to healthy male subjects.

Timeline

Start
2016-03
Primary completion
2016-06
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Fimasartan Small molecule
Subject Rosuvastatin Small molecule

Indications